You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

5 Key Points of Diabetes Management

T2DM Drivers

1) Reducing blood glucose and HbA1c levels reduces the risk of diabetic complications. Intensive therapy has been shown to be superior to conventional therapy in terms or reducing glycemia and diabetic complications.

2) When monotherapy with an oral agent is no longer adequate, combination therapy with 2 or more oral agents has been shown to significantly improve glycemic control.

3) When oral monotherapy or combination oral therapy is no longer adequate, insulin can be added to the regimen to significantly improve glycemic control.

4) Benefits of insulin therapy, such as improved outcomes and glycemic control, outweigh risks such as the potential for inducing hypoglycemia.

5) Type 2 Diabetes mellitus is a disease consisting of two components: insulin resistance and insulin deficiency.

Diabetes Management Options

Diabetes Module V2

This is supported by an unrestricted educational grant by Sanofi-Aventis Pharmaceuticals Education Center.